Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 102934
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.102934
Table 1 Patient characteristics, n (%)/mean ± SD
Parameters
Perioperative complications
Non-perioperative complications
P value
Gender
Male8 (14.5)47 (85.5)0.892
Female5 (15.6)27 (84.4)
Age61.85 ± 13.4861.24 ± 10.700.857
BMI22.54 ± 1.4824.33 ± 3.200.052
Underlying illnesses
Heart disease 1 (6.8)5 (7.7)0.444
Hypertension2 (40.5)30 (15.4)
Diabetes1 (7.7)12 (16.2)
Lung disease0 (0)1 (1.4)
Nervous system disease0 (0)1 (1.4)
Preoperative levels
White blood cell (109/L)6.35 ± 1.975.52 ± 1.750.130
Albumin (g/L)39.35 ± 3.3237.53 ± 4.620.329
Hb (g/L)125.54 ± 19.54122.55 ± 23.600.668
Surgical excision sites
TME5 (41.7)27 (36.5)0.56
Anterior resection4 (33.3)15 (20.3)
Sigmoidectomy0 (0)6 (8.1)
Left hemicolectomy1 (8.3)3 (4.1)
Right hemicolectomy2 (16.7)23 (31.1)
ASA Score
13 (23.1)18 (24.3)0.936
27 (53.8)36 (48.6)
33 (23.1)20 (27.0)
Stage of cancer
001 (1.5%)0.719
I2 (15.4)14 (20.6)
II4 (30.8)29 (42.6)
III7 (53.8)23 (33.8)
IV0(0)1 (1.5)
Table 2 Statistics of inflammation-related parameters between the two groups, mean ± SD
Parameters
Perioperative complications
Non-perioperative complications
P value
PreWBC (109/L)6.35 ± 1.975.52 ± 1.750.130
CRP (mg/L)1.97 ± 2.255.84 ± 11.910.291
Albumin (g/L)39.35 ± 3.3237.53 ± 4.620.329
Hb (g/L)125.54 ± 19.54122.55 ± 23.600.668
Pod1WBC (109/L)10.87 ± 3.2011.45 ± 3.610.589
CRP (mg/L)46.37 ± 80.4725.48 ± 27.460.088
Albumin (g/L)32.09 ± 10.5337.53 ± 4.620.003b
Hb (g/L)122.15 ± 14.77115.17 ± 20.960.253
Pod2WBC (109/L)9.20 ± 2.758.38 ± 2.860.338
CRP (mg/L)73.66 ± 81.0736.56 ± 41.770.017b
Albumin (g/L)33.97 ± 7.5239.27 ± 4.230.001c
Hb (g/L)116.31 ± 16.04113.78 ± 21.900.692
Pod3WBC (109/L)8.31 ± 3.046.76 ± 2.010.037a
CRP (mg/L)89.50 ± 86.6516.35 ± 16.04< 0.001c
Albumin (g/L)37.15 ± 6.3138.97 ± 6.960.414
Hb (g/L)114.00 ± 16.20119.87 ± 18.900.328